 | • レポートコード：MRC23Q36212 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の新生児代謝スクリーニング市場について調査・分析し、世界の新生児代謝スクリーニング市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（血液検査、尿検査）、用途別セグメント分析（病院、専門クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、PerkinElmer、Bio-Rad Laboratories、Trivitron Healthcare Private Limited、BioMedomics, Inc.、Luminex Corporation、MP BIOMEDICALS、Synergy Medical Systems LLP、Agilent Technologies, Inc、Thermo Fisher Scientific, Inc、Zivak Technologies、Covidien Plc、AB Sciex LLC、Waters Corp.、Masimo Corp.、Natus Medical Inc.などが含まれています。世界の新生児代謝スクリーニング市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、新生児代謝スクリーニング市場規模を推定する際に考慮しました。本レポートは、新生児代謝スクリーニングの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、新生児代謝スクリーニングに関するビジネス上の意思決定に役立てることを目的としています。 ・新生児代謝スクリーニング市場の概要 - 新生児代謝スクリーニングのタイプ別セグメント - 世界の新生児代謝スクリーニング市場規模：タイプ別分析（血液検査、尿検査） - 新生児代謝スクリーニングの用途別セグメント - 世界の新生児代謝スクリーニング市場規模：用途別分析（病院、専門クリニック、その他） - 世界の新生児代謝スクリーニング市場規模予測（2018年-2029年） ・新生児代謝スクリーニング市場の成長トレンド - 新生児代謝スクリーニングの地域別市場規模（2018年-2029年） - 新生児代謝スクリーニング市場ダイナミクス - 新生児代謝スクリーニングの業界動向 - 新生児代謝スクリーニング市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：血液検査、尿検査 - 世界の新生児代謝スクリーニングのタイプ別市場規模（2018年-2023年） - 世界の新生児代謝スクリーニングのタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、専門クリニック、その他 - 世界の新生児代謝スクリーニングの用途別市場規模（2018年-2023年） - 世界の新生児代謝スクリーニングの用途別市場規模（2024年-2029年） ・新生児代謝スクリーニングの地域別市場規模 - 北米の新生児代謝スクリーニング市場規模（2018年-2029年） - アメリカの新生児代謝スクリーニング市場規模（2018年-2029年） - ヨーロッパの新生児代謝スクリーニング市場規模（2018年-2029年） - アジア太平洋の新生児代謝スクリーニング市場規模（2018年-2029年） - 中国の新生児代謝スクリーニング市場規模（2018年-2029年） - 日本の新生児代謝スクリーニング市場規模（2018年-2029年） - 韓国の新生児代謝スクリーニング市場規模（2018年-2029年） - インドの新生児代謝スクリーニング市場規模（2018年-2029年） - オーストラリアの新生児代謝スクリーニング市場規模（2018年-2029年） - 中南米の新生児代謝スクリーニング市場規模（2018年-2029年） - 中東・アフリカの新生児代謝スクリーニング市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 PerkinElmer、Bio-Rad Laboratories、Trivitron Healthcare Private Limited、BioMedomics, Inc.、Luminex Corporation、MP BIOMEDICALS、Synergy Medical Systems LLP、Agilent Technologies, Inc、Thermo Fisher Scientific, Inc、Zivak Technologies、Covidien Plc、AB Sciex LLC、Waters Corp.、Masimo Corp.、Natus Medical Inc. ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Newborn Metabolic Screening market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Newborn Metabolic Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Newborn Metabolic Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Newborn Metabolic Screening in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Newborn Metabolic Screening include PerkinElmer, Bio-Rad Laboratories, Trivitron Healthcare Private Limited, BioMedomics, Inc., Luminex Corporation, MP BIOMEDICALS, Synergy Medical Systems LLP, Agilent Technologies, Inc and Thermo Fisher Scientific, Inc, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Newborn Metabolic Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Metabolic Screening.
The Newborn Metabolic Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Newborn Metabolic Screening market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn Metabolic Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
PerkinElmer
Bio-Rad Laboratories
Trivitron Healthcare Private Limited
BioMedomics, Inc.
Luminex Corporation
MP BIOMEDICALS
Synergy Medical Systems LLP
Agilent Technologies, Inc
Thermo Fisher Scientific, Inc
Zivak Technologies
Covidien Plc
AB Sciex LLC
Waters Corp.
Masimo Corp.
Natus Medical Inc.
Segment by Type
Blood Test
Urine Test
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn Metabolic Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn Metabolic Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Blood Test
1.2.3 Urine Test
1.3 Market by Application
1.3.1 Global Newborn Metabolic Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn Metabolic Screening Market Perspective (2018-2029)
2.2 Newborn Metabolic Screening Growth Trends by Region
2.2.1 Global Newborn Metabolic Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Newborn Metabolic Screening Historic Market Size by Region (2018-2023)
2.2.3 Newborn Metabolic Screening Forecasted Market Size by Region (2024-2029)
2.3 Newborn Metabolic Screening Market Dynamics
2.3.1 Newborn Metabolic Screening Industry Trends
2.3.2 Newborn Metabolic Screening Market Drivers
2.3.3 Newborn Metabolic Screening Market Challenges
2.3.4 Newborn Metabolic Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn Metabolic Screening Players by Revenue
3.1.1 Global Top Newborn Metabolic Screening Players by Revenue (2018-2023)
3.1.2 Global Newborn Metabolic Screening Revenue Market Share by Players (2018-2023)
3.2 Global Newborn Metabolic Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Newborn Metabolic Screening Revenue
3.4 Global Newborn Metabolic Screening Market Concentration Ratio
3.4.1 Global Newborn Metabolic Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn Metabolic Screening Revenue in 2022
3.5 Newborn Metabolic Screening Key Players Head office and Area Served
3.6 Key Players Newborn Metabolic Screening Product Solution and Service
3.7 Date of Enter into Newborn Metabolic Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn Metabolic Screening Breakdown Data by Type
4.1 Global Newborn Metabolic Screening Historic Market Size by Type (2018-2023)
4.2 Global Newborn Metabolic Screening Forecasted Market Size by Type (2024-2029)
5 Newborn Metabolic Screening Breakdown Data by Application
5.1 Global Newborn Metabolic Screening Historic Market Size by Application (2018-2023)
5.2 Global Newborn Metabolic Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Newborn Metabolic Screening Market Size (2018-2029)
6.2 North America Newborn Metabolic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Newborn Metabolic Screening Market Size by Country (2018-2023)
6.4 North America Newborn Metabolic Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn Metabolic Screening Market Size (2018-2029)
7.2 Europe Newborn Metabolic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Newborn Metabolic Screening Market Size by Country (2018-2023)
7.4 Europe Newborn Metabolic Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn Metabolic Screening Market Size (2018-2029)
8.2 Asia-Pacific Newborn Metabolic Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Newborn Metabolic Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Newborn Metabolic Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn Metabolic Screening Market Size (2018-2029)
9.2 Latin America Newborn Metabolic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Newborn Metabolic Screening Market Size by Country (2018-2023)
9.4 Latin America Newborn Metabolic Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn Metabolic Screening Market Size (2018-2029)
10.2 Middle East & Africa Newborn Metabolic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Newborn Metabolic Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Newborn Metabolic Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PerkinElmer
11.1.1 PerkinElmer Company Detail
11.1.2 PerkinElmer Business Overview
11.1.3 PerkinElmer Newborn Metabolic Screening Introduction
11.1.4 PerkinElmer Revenue in Newborn Metabolic Screening Business (2018-2023)
11.1.5 PerkinElmer Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Newborn Metabolic Screening Introduction
11.2.4 Bio-Rad Laboratories Revenue in Newborn Metabolic Screening Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Trivitron Healthcare Private Limited
11.3.1 Trivitron Healthcare Private Limited Company Detail
11.3.2 Trivitron Healthcare Private Limited Business Overview
11.3.3 Trivitron Healthcare Private Limited Newborn Metabolic Screening Introduction
11.3.4 Trivitron Healthcare Private Limited Revenue in Newborn Metabolic Screening Business (2018-2023)
11.3.5 Trivitron Healthcare Private Limited Recent Development
11.4 BioMedomics, Inc.
11.4.1 BioMedomics, Inc. Company Detail
11.4.2 BioMedomics, Inc. Business Overview
11.4.3 BioMedomics, Inc. Newborn Metabolic Screening Introduction
11.4.4 BioMedomics, Inc. Revenue in Newborn Metabolic Screening Business (2018-2023)
11.4.5 BioMedomics, Inc. Recent Development
11.5 Luminex Corporation
11.5.1 Luminex Corporation Company Detail
11.5.2 Luminex Corporation Business Overview
11.5.3 Luminex Corporation Newborn Metabolic Screening Introduction
11.5.4 Luminex Corporation Revenue in Newborn Metabolic Screening Business (2018-2023)
11.5.5 Luminex Corporation Recent Development
11.6 MP BIOMEDICALS
11.6.1 MP BIOMEDICALS Company Detail
11.6.2 MP BIOMEDICALS Business Overview
11.6.3 MP BIOMEDICALS Newborn Metabolic Screening Introduction
11.6.4 MP BIOMEDICALS Revenue in Newborn Metabolic Screening Business (2018-2023)
11.6.5 MP BIOMEDICALS Recent Development
11.7 Synergy Medical Systems LLP
11.7.1 Synergy Medical Systems LLP Company Detail
11.7.2 Synergy Medical Systems LLP Business Overview
11.7.3 Synergy Medical Systems LLP Newborn Metabolic Screening Introduction
11.7.4 Synergy Medical Systems LLP Revenue in Newborn Metabolic Screening Business (2018-2023)
11.7.5 Synergy Medical Systems LLP Recent Development
11.8 Agilent Technologies, Inc
11.8.1 Agilent Technologies, Inc Company Detail
11.8.2 Agilent Technologies, Inc Business Overview
11.8.3 Agilent Technologies, Inc Newborn Metabolic Screening Introduction
11.8.4 Agilent Technologies, Inc Revenue in Newborn Metabolic Screening Business (2018-2023)
11.8.5 Agilent Technologies, Inc Recent Development
11.9 Thermo Fisher Scientific, Inc
11.9.1 Thermo Fisher Scientific, Inc Company Detail
11.9.2 Thermo Fisher Scientific, Inc Business Overview
11.9.3 Thermo Fisher Scientific, Inc Newborn Metabolic Screening Introduction
11.9.4 Thermo Fisher Scientific, Inc Revenue in Newborn Metabolic Screening Business (2018-2023)
11.9.5 Thermo Fisher Scientific, Inc Recent Development
11.10 Zivak Technologies
11.10.1 Zivak Technologies Company Detail
11.10.2 Zivak Technologies Business Overview
11.10.3 Zivak Technologies Newborn Metabolic Screening Introduction
11.10.4 Zivak Technologies Revenue in Newborn Metabolic Screening Business (2018-2023)
11.10.5 Zivak Technologies Recent Development
11.11 Covidien Plc
11.11.1 Covidien Plc Company Detail
11.11.2 Covidien Plc Business Overview
11.11.3 Covidien Plc Newborn Metabolic Screening Introduction
11.11.4 Covidien Plc Revenue in Newborn Metabolic Screening Business (2018-2023)
11.11.5 Covidien Plc Recent Development
11.12 AB Sciex LLC
11.12.1 AB Sciex LLC Company Detail
11.12.2 AB Sciex LLC Business Overview
11.12.3 AB Sciex LLC Newborn Metabolic Screening Introduction
11.12.4 AB Sciex LLC Revenue in Newborn Metabolic Screening Business (2018-2023)
11.12.5 AB Sciex LLC Recent Development
11.13 Waters Corp.
11.13.1 Waters Corp. Company Detail
11.13.2 Waters Corp. Business Overview
11.13.3 Waters Corp. Newborn Metabolic Screening Introduction
11.13.4 Waters Corp. Revenue in Newborn Metabolic Screening Business (2018-2023)
11.13.5 Waters Corp. Recent Development
11.14 Masimo Corp.
11.14.1 Masimo Corp. Company Detail
11.14.2 Masimo Corp. Business Overview
11.14.3 Masimo Corp. Newborn Metabolic Screening Introduction
11.14.4 Masimo Corp. Revenue in Newborn Metabolic Screening Business (2018-2023)
11.14.5 Masimo Corp. Recent Development
11.15 Natus Medical Inc.
11.15.1 Natus Medical Inc. Company Detail
11.15.2 Natus Medical Inc. Business Overview
11.15.3 Natus Medical Inc. Newborn Metabolic Screening Introduction
11.15.4 Natus Medical Inc. Revenue in Newborn Metabolic Screening Business (2018-2023)
11.15.5 Natus Medical Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
